General Hospital and Personal Use Device Panel to Meet

The FDA will hold a meeting of the General Hospital and Personal Use Device Panel March 5. The advisory panel will consider recommendations for the clinical risks and benefits of postmarketing actions in response to failures of insulin pumps, the agency says in a Federal Register notice.